IL6 and coronary artery disorder: With respect to CHD, Su et al. observed that serum IL-6 was significantly associated with all-cause mortality and cardiovascular mortality in hospitalized CHD patients (Su et al., 2013), while Arbel et al. identified that the neutrophil/lymphocyte ratio was independently associated with CHD severity and worse 3-year outcomes (Arbel et al., 2012).